The Scientist - Home

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform early-stage treatments.

Every DNA fragment tells a story. Forensic experts use these genetic breadcrumbs to solve old mysteries and modern crimes.

Researchers transformed a plant pathogen weapon into a programmable tool for DNA editing.

Scientists dive into the genomes of whales, elephants, and other animal giants looking for new weapons in the fight against cancer.

Progress in cancer therapies has improved survival rates, but researchers must now battle early-onset cancers.

With a deep love for writing and a growing fascination for science, Hannah Thomasy found her calling at the intersection of both passions.

The second act of a popular reprogramming factor could maximize the potential of iPSCs in research and regenerative medicine.

Scientists identified molecular targets of polycystic ovarian syndrome in rodents and humans, paving the way for improved therapies in the future

A human-specific NOVA1 variant changed mouse vocalizations, potentially providing insights into the evolution of language.

For over a decade, GenomeTrakr has helped scientists trace contaminants from Salmonella to E. coli in the food system.

Overlaying reality with simulations advances research and interventions in human behavior and neurodegenerative disorders.  

On March 7, researchers will rally in Washington, D.C. and other US cities to protest federal policies threatening the future of science.

Studying drug-induced metabolic changes with high-throughput systems shed light on drug modes of action, providing an efficient drug discovery platform.

Psychedelics stimulate the growth of synapses outside the brain, scientists show for the first time.

Advances in stem cell biology and immune cell engineering bring diabetes cell therapies closer to reality.

Boosting cells with a tardigrade protein reduced DNA damage after radiation, offering potential protection for healthy tissue during cancer treatment.

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative therapeutic strategies to antibiotics and fecal transplant.

Basophils trigger a cytokine cascade that improves antitumor immunity in mice, offering potential targets for cancer immunotherapy.